CARLSBAD, Calif., — Life Technologies (NASDAQ: LIFE) today announced the acquisition of Compendia Bioscience, a preeminent cancer bioinformatics company widely used by the pharmaceutical industry to identify novel gene targets for drug discovery and development. Its deep oncology expertise and high-value, proprietary assets enhance Life’s diagnostic development capabilities across multiple platforms, including next-generation sequencing, qPCR […]
SANTA CLARA, Calif.– Affymetrix, Inc. (Nasdaq: AFFX) today reported that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of approximately $18 million from the eBioscience business. The Company expects to report cash-on-hand of approximately $39.6 million as of September 30, 2012, […]
SUNNYVALE, Calif., — Arrayit Corporation (OTCQB: ARYC) is pleased to announce that Arrayit Diagnostics, Inc. (“”AD””) has secured a financing commitment from American Equity Fund, LLC to purchase up to $8 million of the common stock of AD. This financing will commence upon the completion, filing, and approval by the SEC of the S-1 Registration […]
KANSAS CITY, Mo. – Today investigators at Children’s Mercy Hospitals and Clinics in Kansas City reported the first use of whole genome information for diagnosing critically ill infants. As reported in Science Translational Medicine, the team describes STAT-Seq® , a whole genome sequencing approach – from blood sample to returning results to a physician – […]
INDIANAPOLIS, — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. availability of a new HIV-1 viral load test based on the company’s proprietary dual-target approach. The COBAS TaqMan HIV-1 Test v2.0 for use with the High Pure System enables labs to combine an FDA-approved process for manual specimen preparation with an automated real-time […]
SEATTLE, Wash. – NanoString Technologies, Inc., a privately-held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of James A. Johnson as the company’s new Chief Financial Officer (CFO). Mr. Johnson assumes this role from Wayne Burns who will remain with the company in his new position […]
Redwood City, CA – – Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, today announced a partnership with Life Technologies Corporation to develop and deliver a joint solution for rapid, high-confidence interpretation of molecular profiling information from Life Technologies’ diagnostic tests. Ingenuity Systems’ unique software and content will be provided to interpreting […]
Mountain View, CA — Genia Technologies, Inc. today announced a collaboration with investigators at Columbia University and Harvard University to develop a nanopore-based sequencing system that will accelerate the use of DNA sequencing in the clinic. The three-way collaboration focuses on the development of a single molecule sequencing system combining Genia’s standard complementary metal-oxide semiconductor […]
San Francisco, Calif., – CollabRx, Inc. (NASDAQ: CLRX) today announced a multi-year partnership agreement with Life Technologies Corporation for development and commercialization of CollabRx technology and content resources to be used in conjunction with Life Technologies’ global cancer diagnostics development and its laboratory developed test services business. The agreement represents a major step forward by […]
Paris, France,- Cellectis (Alternext: ALCLS), the French genome engineering specialist, announces in the Journal of Biological Chemistry, one of the most respected scientific journals in the world, the publication of a new approach regarding the targeted modification of DNA. The manuscript unmasks novel perspectives and broadens the scope of TALENs TM technology to new therapeutic […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
